Kimia Biosciences Ltd. benchmarking: Perfomance to industry peers

Financial

	Kimia Biosciences	Achyut Healthcare	Krebs Biochem.&Inds
Operational Metrics
Unclassified
R&D as a % of Total Sales	4.19 %	n/a	n/a
Financials
5 yr Average ROE	-335.15 %	1.93 %	37.05 %
5yr average Equity Multiplier	66.02	1.21	-2.13
5yr Average Asset Turnover Ratio	1.14	0.29	0.3
5yr Avg Net Profit Margin	-0.67 %	7.92 %	-55.19 %
Price to Book	12.86	4.35	0.0
P/E	15.5	248.02	0.0
5yr Avg Cash Conversion Cycle	-33.97 Days	36.15 Days	-1144.52 Days
Inventory Days	101.63 Days	38.82 Days	102.59 Days
Days Receivable	98.68 Days	105.12 Days	8.23 Days
Days Payable	171.28 Days	84.53 Days	623.06 Days
5yr Average Interest Coverage Ratio	0.78	272.88	-4.97
5yr Avg ROCE	10.6 %	2.78 %	-23.43 %
5yr Avg Operating Profit Margin	3.89 %	-2.63 %	-34.39 %
5 yr average Debt to Equity	29.85	0.0	-1.88
5yr CAGR Net Profit	13.51 %	122.88 %	-0.84 %
5yr Average Return on Assets	-0.69 %	1.5 %	-16.47 %
Shareholdings
Promoter Holding	74.94 %	47.07 %	72.74 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.0	-19.11 %	0.0
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0

	Kimia Biosciences	Achyut Healthcare	Krebs Biochem.&Inds
Product Wise Break-Up	Product Wise Break-Up Pharmaceutical 100.0 Pharmaceutical Products 0 Sabam-RSS 0 Simvastatin 0 Phenylephrine 0	Product Wise Break-Up Phenylephrine 0 Pharmaceutical Products 100.0 Simvastatin 0 Pharmaceutical 0 Sabam-RSS 0	Product Wise Break-Up Phenylephrine 62.86 Pharmaceutical Products 0 Simvastatin 13.01 Pharmaceutical 0 Sabam-RSS 0 Others 24.13
Location Wise Break-Up	Location Wise Break-Up Domestic 81.72 International 18.28 India 0 Rest of the World 0	Location Wise Break-Up Rest of the World 0 India 98.72 Domestic 0 International 0 Others 1.28	Location Wise Break-Up Rest of the World 0 India 100.0 Domestic 0 International 0